Atopic dermatitis: Skin-directed management

Pediatrics

Volumn 134, Issue 6, 2014, Pages e1735-e1744

  Tollefson, Megha M ^a   Bruckner, Anna L ^a   Cohen, Bernard A ^a   Antaya, Richard ^a   Horii, Kim ^a   Silverberg, Nanette B ^a   Wright, Teresa ^a  

^a NONE

Author keywords

Atopic dermatitis; Eczema; Skin care; Topical corticosteroids; Treatment

Indexed keywords

ALCLOMETASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BUDESONIDE; CALCINEURIN INHIBITOR; CLOBETASOL PROPIONATE; CLOCORTOLONE PIVALATE; DESONIDE; DESOXIMETASONE; DETERGENT; DIFLORASONE DIACETATE; FLUDROXYCORTIDE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; FLUTICASONE PROPIONATE; HALCINONIDE; HYDROCORTISONE; HYDROCORTISONE 17 BUTYRATE 21 PROPIONATE; HYDROCORTISONE BUTYRATE; HYDROCORTISONE VALERATE; MOMETASONE FUROATE; PIMECROLIMUS; PLACEBO; PREDNICARBATE; STEROID; TACROLIMUS; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; ULOBETASOL PROPIONATE; UNINDEXED DRUG; ANTIINFLAMMATORY AGENT; CORTICOSTEROID;

ADRENAL SUPPRESSION; ARTICLE; ATOPIC DERMATITIS; BACTERIAL SKIN DISEASE; CATARACT; DEHYDRATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; FOOD ALLERGY; HUMAN; INTRAOCULAR HYPERTENSION; LYMPHOMA; MEDICATION COMPLIANCE; META ANALYSIS (TOPIC); PATHOGENESIS; PATIENT EDUCATION; PROGNOSIS; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN ATROPHY; SKIN BURNING SENSATION; SKIN CANCER; SKIN CARE; STRIA; TELANGIECTASIA; TREATMENT DURATION; VIRAL SKIN DISEASE; CHILD; COOPERATION; DERMATITIS, ATOPIC; EDUCATION; INTERDISCIPLINARY COMMUNICATION; MULTIMODALITY CANCER THERAPY; PARENT; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PROCEDURES; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CALCINEURIN INHIBITORS; CHILD; COMBINED MODALITY THERAPY; COOPERATIVE BEHAVIOR; DERMATITIS, ATOPIC; GUIDELINE ADHERENCE; HUMANS; INTERDISCIPLINARY COMMUNICATION; PARENTS; PRIMARY HEALTH CARE; PROGNOSIS; REFERRAL AND CONSULTATION; SKIN CARE;

EID: 84913589263     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-2812     Document Type: Article

References (61)

1. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011;131(1):67-73
2. Horii KA, Simon SD, Liu DY, Sharma V. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns. Pediatrics. 2007;120(3). Available at: www.pediatrics.org/cgi/content/full/120/3/e527
3. Stern RS, Nelson C. The diminishing role of the dermatologist in the offi ce-based care of cutaneous diseases. J Am Acad Dermatol. 1993;29(5 pt 1):773-777
4. Pletcher BA, Rimsza ME, Cull WL, Shipman SA, Shugerman RP, O'Connor KG. Primary care pediatricians' satisfaction with subspecialty care, perceived supply, and barriers to care. J Pediatr. 2010;156(6):1011-1015
5. Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003;49(6):1088-1095
6. Schneider L, Tilles S, Lio P, et al Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2):295-299
7. Ring J, Alomar A, Bieber T, et al; European Dermatology Forum; European Academy of Dermatology and Venereology; European Task Force on Atopic Dermatitis; European Federation of Allergy; European Society of Pediatric Dermatology; Global Allergy and Asthma European Network. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol. 2012;26(9):1176-1193
8. Ring J, Alomar A, Bieber T, et al; European Dermatology Forum (EDF); European Academy of Dermatology and Venereology (EADV); European Federation of Allergy (EFA); European Task Force on Atopic Dermatitis (ETFAD); European Society of Pediatric Dermatology (ESPD); Global Allergy and Asthma European Network (GA2LEN). Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045-1060
9. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-351
10. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116-132
11. Elias PM, Steinhoff M. "Outside-to-inside"(and now back to "outside ") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol. 2008;128(5):1067-1070
12. Chamlin SL, Lai JS, Cella D, et al. Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness. Arch Dermatol. 2007;143(6):768-772
13. Brenninkmeijer EE, Legierse CM, Sillevis Smitt JH, Last BF, Grootenhuis MA, Bos JD. The course of life of patients with childhood atopic dermatitis. Pediatr Dermatol. 2009;26(1):14-22
14. Slattery MJ, Essex MJ, Paletz EM, et al. Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol. 2011;128(3):668-671
15. Al Shobaili HA. The impact of childhood atopic dermatitis on the patients' family. Pediatr Dermatol. 2010;27(6):618-623
16. Moore K, David TJ, Murray CS, Child F, Arkwright PD. Effect of childhood eczema and asthma on parental sleep and wellbeing: a prospective comparative study. Br J Dermatol. 2006;154(3):514-518
17. O'Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clin Exp Allergy. 2010;40(7):965-972
18. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441-446
19. Margolis DJ, Apter AJ, Gupta J, et al. The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort. J Allergy Clin Immunol. 2012;130(4):912-917
20. Brown SJ, Kroboth K, Sandilands A, et al. Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect. J Invest Dermatol. 2012;132(1):98-104
21. Jakasa I, Koster ES, Calkoen F, et al. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol. 2011;131(2):540-542
22. Thompson MM, Tofte SJ, Simpson EL, Hanifin JM. Patterns of care and referral in children with atopic dermatitis and concern for food allergy. Dermatol Ther. 2006;19(2):91-96
23. Thompson MM, Hanifin JM. Effective therapy of childhood atopic dermatitis allays food allergy concerns. J Am Acad Dermatol. 2005;53(2 suppl 2):S214-S219
24. Sampson HA. Update on food allergy. J Allergy Clin Immunol. 2004;113(5):805-819, quiz 820
25. Boyce JA, Assa'ad A, Burks AW, et al; NIAID-Sponsored Expert Panel. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(suppl 6):S1-S58
26. Werfel T, Breuer K. Role of food allergy in atopic dermatitis. Curr Opin Allergy Clin Immunol. 2004;4(5):379-385
27. Illi S, von Mutius E, Lau S, et al; Multicenter Allergy Study Group. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004;113(5):925-931
28. Wahn U, Warner J, Simons FE, et al; EPAAC Study Group. IgE antibody responses in young children with atopic dermatitis. Pediatr Allergy Immunol. 2008;19(4):332-336
29. Bath-Hextall F, Delamere FM, Williams HC. Dietary exclusions for improving established atopic eczema in adults and children: systematic review. Allergy. 2009;64(2):258-264
30. Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008;122(4):812-824
31. Tan RA, Corren J. The relationship of rhinitis and asthma, sinusitis, food allergy, and eczema. Immunol Allergy Clin North Am. 2011;31(3):481-491
32. Simonsen AB, Deleuran M, Johansen JD, Sommerlund M. Contact allergy and allergic contact dermatitis in children - a review of current data. Contact Dermat. 2011;65(5):254-265
33. Staab D, Diepgen TL, Fartasch M, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ. 2006;332(7547):933-938
34. Chisolm SS, Taylor SL, Balkrishnan R, Feldman SR. Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol. 2008;59(4):677-683
35. Rork JF, Sheehan WJ, Gaffin JM, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148(3):391-392
36. Dohil MA, Eichenfield LF. A treatment approach for atopic dermatitis. Pediatr Ann. 2005;34(3):201-210
37. Short RW, Chan JL, Choi JM, Egbert BM, Rehmus WE, Kimball AB. Effects of moisturization on epidermal homeostasis and differentiation. Clin Exp Dermatol. 2007;32(1):88-90
38. Lodén M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol. 1999;140(2):264-267
39. Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149(3):582-589
40. Miller DW, Koch SB, Yentzer BA, et al. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol. 2011;10(5):531-537
41. Callen J, Chamlin S, Eichenfield LF, et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol. 2007;156(2):203-221
42. Aubert-Wastiaux H, Moret L, Le Rhun A, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165(4):808-814
43. Kojima R, Fujiwara T, Matsuda A, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30(1):29-35
44. Dabade TS, Davis DM, Wetter DA, et al. Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: experience with 218 patients over 30 years at Mayo Clinic. J Am Acad Dermatol. 2012;67(1):100-106
45. Chen SL, Yan J, Wang FS. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials. J Dermatolog Treat. 2010;21(3):144-156
46. Ring J, Möhrenschlager M, Henkel V. The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy. Drug Saf. 2008;31(3):185-198
47. Wahn U, Bos JD, Goodfield M, et al; Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics. 2002;110(1 pt 1). Available at: www.pediatrics.org/cgi/content/full/110/1/e2
48. Margolis DJ, Hoffstad O, Bilker W. Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults. Dermatology. 2007;214(4):289-295
49. Thac¸i D, Reitamo S, Gonzalez Ensenat MA, et al; European Tacrolimus Ointment Study Group. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Br J Dermatol. 2008;159(6):1348-1356
50. Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2011;164(2):415-428
51. Darsow U, Pfab F, Valet M, et al. Pruritus and atopic dermatitis. Clin Rev Allergy Immunol. 2011;41(3):237-244
52. Buddenkotte J, Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy. 2010;65(7):805-821
53. Yosipovitch G, Papoiu AD. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep. 2008;8(4):306-311
54. Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. 1999;135(12):1522-1525
55. Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010;125(1):4-13, quiz 14-15
56. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123(5). Available at: www.pediatrics.org/cgi/content/full/123/5/e808
57. Balma-Mena A, Lara-Corrales I, Zeller J, et al. Colonization with community-acquired methicillin-resistant Staphylococcus aureus in children with atopic dermatitis: a crosssectional study. Int J Dermatol. 2011;50(6):682-688
58. Sugarman JL, Hersh AL, Okamura T, Howard R, Frieden IJ. A retrospective review of streptococcal infections in pediatric atopic dermatitis. Pediatr Dermatol. 2011;28(3):230-234
59. Mathes EF, Oza V, Frieden IJ, et al. "Eczemacoxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics. 2013;132(1). Available at: www.pediatrics. org/cgi/content/full/132/1/e149
60. Revere K, Davidson SL. Update on management of herpes keratitis in children. Curr Opin Ophthalmol. 2013;24(4):343-347
61. Reed JL, Scott DE, Bray M. Eczema vaccinatum. Clin Infect Dis. 2012;54(6):832-840